Banco Santander Brasil (NYSE:BSBR) reported fourth-quarter 2025 net income of BRL 4.1 billion, up nearly 6% year over year ...
Presentations Highlight Potential Benefits of Therapies Incorporating J-Brain Cargo®, JCR’s Proprietary, Blood-Brain Barrier-Penetrating Technology -HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals ...